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Harlequin syndrome: does
a cranial autonomic neuropathy
influence headache?
Peter Drummond,1 James W Lance2
The paper by Viana et al1 analyses the
relationship between Harlequin syndrome2
and headache. One facet of this interesting
syndrome is the demonstration of pupil-
lary signs by pharmacological studies
explicable by the sudden onset of para-
sympathetic and sympathetic deﬁcit,
implicating an autonomic neuropathy
mediated by an autoimmune process or
viral infection.3
Sympathetic innervation of human
cerebral and extracranial circulation is well
documented. Parasympathetic innervation
of cranial arteries has been established in
rat, cat and monkey, but information
on humans is meagre. Stimulation of the
pre- or post-ganglionic ﬁbres of the sphe-
nopalatine ganglion in animals increases
cerebral blood ﬂow, probably via orbital
rami from the ganglion looping back to
the internal carotid artery, and projecting
directly to the external carotid artery.4
A clinical marker of parasympathetic
activity in man is the redness and lacri-
mation of the ipsilateral eye and discharge
from the nostril in most episodes of
cluster headache and some of migraine,
during which the outﬂow of vasoactive
intestinal polypeptide is enhanced in the
jugular venous blood.5
Parasympathetic pre-ganglionic ﬁbres
for the eye originate in the Edinger-West-
phal nucleus of the midbrain, and travel
with the oculomotor nerve to the ciliary
ganglion where they synapse with post-
ganglionic distribution to the pupils
through short ciliary nerves. Facial para-
sympathetic ﬁbres are derived from the
superior salivatory nucleus in the brain-
stem, and synapse in the sphenopalatine
ganglion, with post-ganglionic distribu-
tion to cerebral arteries, and the vascula-
ture of glands in the eyes, nose and
mouth.6 If this autonomic outﬂow was
also affected in Harlequin syndrome, some
alteration of headache characteristics
might be expected.
Following the classic studies by Harold G
Wolff and colleagues that reported frontal
branches of the superﬁcial temporal artery
dilate on the side affected by migraine
headache and subside with the headache
after the administration of ergotamine,
migraine was regarded as a ‘vascular head-
ache’.7 The pulsatile nature (‘throbbing’)
of migraine headache, the bulging
of preexisting burr holes at the height of
headache, and relief by compression of
temporal and common carotid arteries8
support the concept of a vascular contri-
bution to migraine and other related
headaches. Likewise, in cluster headache,
perivascular inﬂammation or attack-driven
parasympathetic vasodilator reﬂexes could
irritate nociceptive ﬁbres that travel with
cranial arteries, resulting in the rapid esca-
lation of pain.9 In general terms, any
physical or pharmacological agent that
dilates cranial vessels aggravates the
tendency to primary headaches, and any
agent causing vasoconstriction reduces it.
Thus, loss of sympathetic vasoconstrictor
tone in cranial vessels could intensify pain.
Of the eight case histories analysed by
Viana and her colleagues, three patients
had headache during the unilateral ﬂushing
due to exertion, but one was contralateral
to the ﬂushing side. Recurrence of head-
aches with migrainous features in the other
ﬁve cases reported was not related to the
episodic ﬂushing of Harlequin syndrome.
The authors conclude from this inter-
esting study that migraine and Harlequin
syndrome are pathologically independent.
The lack of any correlation suggests that
the cranial parasympathetic deﬁcit in
Harlequin syndrome is limited to output
from the ciliary ganglion, and that there is
no signiﬁcant interference with cerebro-
vascular innervation.
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